Terms: = Liver cancer AND FGFR1OP, FOP, 11116, ENSG00000213066
15 results:
1. TDF and TAF inhibit liver cancer cell migration, invasion via p7TP3.
Zhao J; Zhou L; Zhang Y; Cheng J; Zeng Y; Li X
Sci Rep; 2024 Apr; 14(1):8161. PubMed ID: 38589540
[TBL] [Abstract] [Full Text] [Related]
2. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10.
Cheng X; Wu C; Xu H; Zou R; Li T; Ye S
Aging (Albany NY); 2024 Feb; 16(4):3716-3733. PubMed ID: 38364252
[TBL] [Abstract] [Full Text] [Related]
3. Scientific evidence supporting the newly developed one-health labeling tool "Med-Index": an umbrella systematic review on health benefits of mediterranean diet principles and adherence in a planeterranean perspective.
Zupo R; Castellana F; Piscitelli P; Crupi P; Desantis A; Greco E; Severino FP; Pulimeno M; Guazzini A; Kyriakides TC; Vasiliou V; Trichopoulou A; Soldati L; La Vecchia C; De Gaetano G; Donati MB; Colao A; Miani A; Corbo F; Clodoveo ML
J Transl Med; 2023 Oct; 21(1):755. PubMed ID: 37885010
[TBL] [Abstract] [Full Text] [Related]
4. CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway.
Wang C; Cao F; Cao J; Jiao Z; You Y; Xiong Y; Zhao W; Wang X
J Transl Med; 2023 Aug; 21(1):539. PubMed ID: 37573318
[TBL] [Abstract] [Full Text] [Related]
5. Frizzled-3 suppression overcomes multidrug chemoresistance by Wnt/β-catenin signaling pathway inhibition in hepatocellular carcinoma cells.
Meng Z; Liu Q; Liu Y; Yang Y; Shao C; Zhang S
J Chemother; 2023 Nov; 35(7):653-661. PubMed ID: 36843499
[TBL] [Abstract] [Full Text] [Related]
6. Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitors.
Engers DW; Bollinger SR; Felts AS; Vadukoot AK; Williams CH; Blobaum AL; Lindsley CW; Hong CC; Hopkins CR
Bioorg Med Chem Lett; 2020 Sep; 30(18):127418. PubMed ID: 32750526
[TBL] [Abstract] [Full Text] [Related]
7. Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma.
Chang HL; Bamodu OA; Ong JR; Lee WH; Yeh CT; Tsai JT
Cells; 2020 Apr; 9(4):. PubMed ID: 32326045
[TBL] [Abstract] [Full Text] [Related]
8.
Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
[TBL] [Abstract] [Full Text] [Related]
9. microRNA-485-5p inhibits the progression of hepatocellular carcinoma through blocking the WBP2/Wnt signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Signal; 2020 Feb; 66():109466. PubMed ID: 31706018
[TBL] [Abstract] [Full Text] [Related]
10. Psychological burden and resilience factors in patients with Alveolar Echinococcosis - A cross-sectional study.
Nikendei C; Greinacher A; Berkunova A; Junghanss T; Stojkovic M
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007082. PubMed ID: 30615695
[TBL] [Abstract] [Full Text] [Related]
11. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract] [Full Text] [Related]
12. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
Katoh M
Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
[TBL] [Abstract] [Full Text] [Related]
13. Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma.
Ilmer M; Garnier A; Vykoukal J; Alt E; von Schweinitz D; Kappler R; Berger M
Mol Cancer Ther; 2015 Dec; 14(12):2712-21. PubMed ID: 26516161
[TBL] [Abstract] [Full Text] [Related]
14. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract] [Full Text] [Related]
15. Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Bacigalupo ML; Manzi M; Espelt MV; Gentilini LD; Compagno D; Laderach DJ; Wolfenstein-Todel C; Rabinovich GA; Troncoso MF
J Cell Physiol; 2015 Jun; 230(6):1298-309. PubMed ID: 25469885
[TBL] [Abstract] [Full Text] [Related]